A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With PNH

Clinical trial NCT04085601 · COMPLETED

Trial details

NCT number: NCT04085601
Sponsor: Apellis Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria

Start date: 2019-08-27
Primary completion: 2021-06-23
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.